Search - tctmd.com

Displaying 1 - 20 of 36

Sort: Relevancy | Date

News Industry News

Corvia Medical Announces Randomization of First Patient in the RESPONDER-HF Confirmatory Trial

December 06, 2022

News Industry News

Landmark REDUCE LAP-HF II Trial Demonstrates Clinical Benefit of Corvia Atrial Shunt in Large Segment of Heart Failure Patients

February 02, 2022

News Industry News

Corvia Medical Completes Randomization In Reduce Lap-Hf II Pivotal Trial And Gains Fda Authorization To Provide Continued Access For The Corvia Atrial Shunt

November 17, 2020

News Industry News

preCARDIA Enrolls First Patient in Early Feasibility Study

August 15, 2019

News Industry News

Nanowear Announces Clinical Launch of NanoSENSE, a Heart Failure Management and Alert Diagnostic Validation Study

July 22, 2019

News Industry News

New study finds both components of blood pressure predict heart attack, stroke risk

July 17, 2019

News Industry News

Endotronix Enrolls First Patient in SIRONA II CE Mark Trial

July 15, 2019

News Industry News

U.S. FDA Grants Fast Track Designation to Empagliflozin for the Treatment of Chronic Heart Failure

June 26, 2019

News Industry News

Abbott Launches Next-Generation Detection Technology In The U.S. And Europe, Offering A Smarter Approach To 24/7 Heart Monitoring For People With Irregular Heartbeats

May 06, 2019

News Industry News

Abiomed Announces European Approval (CE Marking) for Impella 5.5™ and First Patient Treated at University Heart Center Hamburg

April 05, 2018

News Industry News

Edwards' Acumen Hypotension Prediction Index Launches In The U.S.

March 19, 2018

News Industry News

Boston Scientific Announces U.S. FDA Approval for MRI Labeling on High-Voltage Devices and U.S. Launch of Resonate™ Devices with the HeartLogic™ Heart Failure Diagnostic

September 25, 2017

News Industry News

Boston Scientific Announces Positive Late-Breaking Clinical Trial Data for the HeartLogic™ Heart Failure Diagnostic

September 19, 2017

News Industry News

Medtronic First to Receive FDA Approval for MR-Conditional Quadripolar Cardiac Resynchronization Therapy-Pacemakers

May 11, 2017

News Industry News

Heart Metabolics Announces Initiation Of Phase 2b Study Of Perhexiline For Hypertrophic Cardiomyopathy

August 31, 2016

News Industry News

Capricor Therapeutics Reports Positive 12-Month Data from the DYNAMIC Clinical Trial

June 17, 2016

News Industry News

BIOTRONIK Announces FDA Approval of MR Conditional Cardiac Resynchronization Defibrillators

May 04, 2016

News Industry News

Two Year ROADMAP Data Showcases the Potential Benefits of HeartMate II LVAD in Ambulatory Heart Failure Patients

April 29, 2016

News Industry News

HeartWare Completes Enrollment In HVAD® System LATERAL Study™

April 28, 2016

News Industry News

NanoCor Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) for Carfostin®

April 20, 2016

Advertisement

Corvia Medical Announces Randomization of First Patient in the RESPONDER-HF Confirmatory Trial

Landmark REDUCE LAP-HF II Trial Demonstrates Clinical Benefit of Corvia Atrial Shunt in Large Segment of Heart Failure Patients

Corvia Medical Completes Randomization In Reduce Lap-Hf II Pivotal Trial And Gains Fda Authorization To Provide Continued Access For The Corvia Atrial Shunt

preCARDIA Enrolls First Patient in Early Feasibility Study

Nanowear Announces Clinical Launch of NanoSENSE, a Heart Failure Management and Alert Diagnostic Validation Study

New study finds both components of blood pressure predict heart attack, stroke risk

Endotronix Enrolls First Patient in SIRONA II CE Mark Trial

U.S. FDA Grants Fast Track Designation to Empagliflozin for the Treatment of Chronic Heart Failure

Abbott Launches Next-Generation Detection Technology In The U.S. And Europe, Offering A Smarter Approach To 24/7 Heart Monitoring For People With Irregular Heartbeats

Abiomed Announces European Approval (CE Marking) for Impella 5.5™ and First Patient Treated at University Heart Center Hamburg

Edwards' Acumen Hypotension Prediction Index Launches In The U.S.

Boston Scientific Announces U.S. FDA Approval for MRI Labeling on High-Voltage Devices and U.S. Launch of Resonate™ Devices with the HeartLogic™ Heart Failure Diagnostic

Boston Scientific Announces Positive Late-Breaking Clinical Trial Data for the HeartLogic™ Heart Failure Diagnostic

Medtronic First to Receive FDA Approval for MR-Conditional Quadripolar Cardiac Resynchronization Therapy-Pacemakers

Heart Metabolics Announces Initiation Of Phase 2b Study Of Perhexiline For Hypertrophic Cardiomyopathy

Capricor Therapeutics Reports Positive 12-Month Data from the DYNAMIC Clinical Trial

BIOTRONIK Announces FDA Approval of MR Conditional Cardiac Resynchronization Defibrillators

Two Year ROADMAP Data Showcases the Potential Benefits of HeartMate II LVAD in Ambulatory Heart Failure Patients

HeartWare Completes Enrollment In HVAD® System LATERAL Study™

NanoCor Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) for Carfostin®

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content